Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of the peripheral nervous system

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jns.12099PMID 25582874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.

  2014cited by this paper
• Intra‐axonal protein aggregation in the peripheral nervous system

  2014influential reference
• Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation

  2014cited by this paper
• Prospective assessment of peripheral neuropathy in Duodopa‐treated parkinsonian patients

  2014cited by this paper
• Lewy body pathology in a patient with a homozygous Parkin deletion

  2013cited by this paper
• Nonmotor and extracerebellar features in Machado‐Joseph disease: A review

  2013cited by this paper
• The Association Between ß-Glucocerebrosidase Mutations and Parkinsonism

  2013cited by this paper
• Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study

  2013cited by this paper
• Severe ataxic polyneuropathy associated with chronic levodopa use in Parkinson's disease.

  2013influential reference
• Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery.

  2013cited by this paper
• Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease?

  2013cited by this paper
• Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation

  2013cited by this paper
• Autosomal dominant mutations in POLG and C10orf2: association with late onset chronic progressive external ophthalmoplegia and Parkinsonism in two patients

  2013influential reference
• Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: a case report and an update on the state of art.

  2013cited by this paper
• Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results.

  2013cited by this paper
• Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease

  2013influential reference
• Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease

  2013cited by this paper
• Levodopa, vitamins, ageing and the neuropathy of Parkinson’s disease

  2013influential reference
• Novel mutation in ATP13A2 widens the spectrum of Kufor‐Rakeb syndrome (PARK9)

  2012cited by this paper
• Syndromes of neurodegeneration with brain iron accumulation.

  2012influential reference
• Machado-Joseph disease/spinocerebellar ataxia type 3.

  2012cited by this paper
• Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.

  2012cited by this paper
• Neurodegeneration with brain iron accumulation: a diagnostic algorithm.

  2012cited by this paper
• Neuropathy in Parkinson disease: Prevalence and determinants

  2012cited by this paper
• Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert

  2012cited by this paper
• Current concepts and controversies in neurodegeneration with brain iron accumulation.

  2012influential reference
• MPV17 Mutations Causing Adult-Onset Multisystemic Disorder With Multiple Mitochondrial DNA Deletions.

  2012cited by this paper
• The neuropathology of genetic Parkinson's disease

  2012cited by this paper
• Mitochondria and peripheral neuropathies.

  2012cited by this paper
• Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS

  2012cited by this paper
• Toward understanding Machado-Joseph disease.

  2012cited by this paper
• FXTAS

  2012cited by this paper
• Lysosomal dysfunction in Parkinson disease

  2012cited by this paper
• SCA3 presenting as an isolated axonal polyneuropathy.

  2011cited by this paper
• TWINKLE gene mutation: report of a French family with an autosomal dominant progressive external ophthalmoplegia and literature review

  2011cited by this paper
• Has “levodopa‐induced neuropathy” been reported in Parkinson's disease clinical trials?

  2011cited by this paper
• Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.

  2011cited by this paper
• Parkinson disease and polyneuropathy

  2011cited by this paper
• Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.

  2011cited by this paper
• Patient page. Parkinson disease and polyneuropathy. About Parkinson disease.

  2011cited by this paper
• Neuropathy in Parkinson disease

  2011cited by this paper
• Mitochondrial DNA polymerase γ mutations: an ever expanding molecular and clinical spectrum

  2011cited by this paper
• POLG-related disorders

  2011cited by this paper
• Parkinson disease, l-dopa, and neuropathy

  2011cited by this paper
• POLG1-Related and other “Mitochondrial Parkinsonisms”: an Overview

  2011cited by this paper
• Neuropathy in idiopathic Parkinson disease: An Iatrogenic problem?

  2011cited by this paper
• Caring for Machado-Joseph disease: current understanding and how to help patients.

  2010cited by this paper
• Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease

  2010cited by this paper
• Axonal inclusions in spinocerebellar ataxia type 3

  2010cited by this paper
• A case series of peripheral neuropathy in patients with Parkinson's disease

  2010cited by this paper
• The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)

  2010cited by this paper
• Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations

  2010influential reference
• Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome.

  2010cited by this paper
• Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy

  2010influential reference
• Neuropathy as a potential complication of levodopa use in Parkinson's disease: A Pharmacological and Pharmacovigilance point of view

  2010cited by this paper
• The fragile x-associated tremor and ataxia syndrome (FXTAS).

  2010cited by this paper
• Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.

  2010cited by this paper
• Mitochondrial DNA

  2009cited by this paper
• Alpha‐synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions

  2009influential reference
• Peripheral nervous system pathology in fragile X tremor/ataxia syndrome (FXTAS)

  2009cited by this paper
• Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.

  2009cited by this paper
• Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy

  2009cited by this paper
• Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.

  2009cited by this paper
• ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature

  2008cited by this paper
• Neuropathy as a potential complication of levodopa use in Parkinson's disease

  2008cited by this paper
• Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy.

  2008cited by this paper
• Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene.

  2008influential reference
• Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism.

  2008influential reference
• Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism.

  2007cited by this paper
• CAG repeat disorder models and human neuropathology: similarities and differences

  2007cited by this paper
• Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys

  2007cited by this paper
• Neuropathic features in fragile X premutation carriers

  2007cited by this paper
• Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA

  2007cited by this paper
• Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle.

  2007cited by this paper
• Neuropathy as a presenting feature in fragile X‐associated tremor/ataxia syndrome

  2007cited by this paper
• Fragile X‐associated tremor/ataxia syndrome: Intrafamilial variability and the size of the FMR1 premutation CGG repeat

  2007cited by this paper
• Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).

  2006influential reference
• Early‐onset familial parkinsonism due to POLG mutations

  2006influential reference
• Gaucher Disease and the Synucleinopathies

  2006cited by this paper
• A polymorphic polymerase.

  2006cited by this paper
• Protein composition of the intranuclear inclusions of FXTAS.

  2006cited by this paper
• The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.

  2006influential reference
• Reduced amplitude of the sural nerve sensory action potential in PARK2 patients

  2005influential reference
• Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome.

  2005cited by this paper
• Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers

  2005cited by this paper
• Chediak‐Higashi syndrome with parkinsonism

  2004cited by this paper
• Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration.

  2004cited by this paper
• Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation.

  2004cited by this paper
• Aging in individuals with the FMR1 mutation.

  2004cited by this paper
• Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG‐repeat diseases

  2004cited by this paper
• A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism.

  2004cited by this paper
• Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

  2004influential reference
• A Novel Polymerase γ Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism

  2004influential reference
• Does parkin play a role in the peripheral nervous system? A family report

  2004influential reference
• Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2).

  2003influential reference
• Parkin disease: a phenotypic study of a large case series.

  2003cited by this paper
• Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

  2003cited by this paper
• How much phenotypic variation can be attributed to parkin genotype?

  2003cited by this paper
• Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literature

  2002cited by this paper
• Characterization of parkin in bovine peripheral nerve.

  2002cited by this paper

• Unraveling Peripheral Neuropathy in Parkinsonism from Acquired to Genetic Forms: A Review with Diagnostic Framework for Clinicians.

  2026cites this paper
• Large-fiber neuropathy in Parkinson’s disease: a narrative review

  2024cites this paper
• An in vitro study: Prebiotic Effects of Edible Palm Hearts in Batch Human Fecal Fermentation System.

  2022cites this paper
• Electroneurography abnormality in Parkinson’s disease: a potential biomarker to help diagnosis

  2022cites this paper
• Parkinson-related neuropathy

  2021cites this paper
• Lack of evidence for association of UQCRC1 with autosomal dominant Parkinson's disease in Caucasian families

  2021cites this paper
• Effectiveness of clinical exome sequencing in adult patients with difficult‐to‐diagnose neurological disorders

  2021cites this paper
• Levodopa‐Induced Neuropathy: A Systematic Review

  2018cites this paper
• Phenotypic spectrum of POLG1 mutations

  2018cites this paper
• Hampered Vitamin B12 Metabolism in Gaucher Disease

  2017cites this paper
• Corneal nerve microstructure in Parkinson's disease.

  2017cites this paper
• Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson’s disease

  2017cites this paper
• 2′,3′-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

  2017cites this paper
• Clinical correlates of sural neurography impairment within normal limits in patients with Parkinsons disease.

  2017cites this paper
• The peripheral nerve involvement in Parkinson Disease: A multifaceted phenomenon.

  2016cites this paper
• Parkinsonism in a patient with Leber hereditary optic neuropathy (LHON).

  2015cites this paper
• SIL1-related Marinesco-Sjoegren syndrome (MSS) with associated motor neuronopathy and bradykinetic movement disorder.

  2015cites this paper